Loading clinical trials...
Loading clinical trials...
The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnose...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Intra-Cellular Therapies, Inc.
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT06370988 · Bipolar Depression, Bipolar Disorder, and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT06524505 · Bipolar Depression
NCT06599099 · Bipolar Depression
Clinical Site
Rogers, Arkansas
Clinical Site
Cerritos, California
Clinical Site
Costa Mesa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions